From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

FinnCap – the legacy of MSM postergirl Sam Smith – truly dismal results ahead of Cenkos merger

By Tom Winnifrith, the Sheriff of AIM | Thursday 13 July 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


IPO’d by Sam Smith, the woman celebrated by the sisterhood and woke media as the postergirl for feminists in the City, at 27p per share, shares in FinnCap (FCAP) are just 7.75p today after the publication of shockingly bad results for the year to March 31. Smith stepped down in September and within weeks there was an awful profits warning and the new CEO had to start slashing costs to survive. Then came a merger with also suffering Cenkos (CNKS), two drunks propping each other up. This is the legacy of Sam Smith, who told the Daily Mail she only stepped down to start getting some “how’s your father.” The reality is Smith fecked it up.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

Time left: 04:05:20